PhaseBio Pharmaceuticals, Inc. (PHAS)
Revenue Growth
-97.99%
Quarterly · Period ending:
PHAS Revenue Growth
Year-over-year change vs the same period a year earlier
Latest reported-97.99%period ending
Latest reported-97.99%period ending
PHAS Quarterly Revenue YoY % (-41.36% → -97.99%)
Year-over-year change
High-resolution chart · PNG
PHAS revenue growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Revenue Growth |
|---|---|
| -97.988% | |
| 49,374,999,999,900% | |
| 39.0041% | |
| 1,370.5548% | |
| -100% | |
| -100% | |
| 0% | |
| 0% | |
| -50.9954% | |
| 197.2763% | |
| -41.3625% |